Litcius/Paper detail

In silico screening of potent inhibitors against COVID-19 key targets from a library of FDA-approved drugs

Mohammad A. Elmorsy, Ahmed M. El-Baz, Nashwa H. Mohamed, Rafa Almeer, Mohamed M. Abdel‐Daim, Galal Yahya

2021Environmental Science and Pollution Research15 citationsDOIOpen Access PDF

Topics & Concepts

PharmacologyMedicineCoronavirus disease 2019 (COVID-19)AmprenavirCoronavirusDrugDiseaseChemistryInternal medicineInfectious disease (medical specialty)ProteaseEnzymeHIV-1 proteaseBiochemistrySARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesComputational Drug Discovery Methods
In silico screening of potent inhibitors against COVID-19 key targets from a library of FDA-approved drugs | Litcius